You are here

You are here

Ian M. Armitage

Professor Emeritus


Fax: (612) 625-2163

Ph.D., University of British Columbia, 1972

Research Description

My laboratory is involved with the development and application of state-of-the-art multinuclear, multidimensional magnetic resonance methods to elucidate the structure, dynamics and mechanism of action of biological macromolecules. The strategy that is frequently used to focus on a particular aspect of a complex biological system such as an enzyme's active site or intermediates in the reaction profile, is the selective observation of less abundant nuclei present naturally or incorporated by specific biosynthetic or chemical labeling procedures. Specific systems under current investigation include: metalloproteins involved in metal homeostasis, metallothioneins, which includes studies of their role in the activation of zinc-finger containing transcription factors and the physiological role of the brain specific metallothionein, MT3, in Alzheimer's disease; and molecules involved in the immune response, the immunosuppressive drug cyclosporin A (CsA), and its cytosolic receptor protein, cyclophilin (CyP) and the penultimate interaction of the CsA:CyP complex with calcineurin.

Another area of past active research involved fundamental studies of factors affecting the relaxation (MRI) of protons in tissue with applications to clinical magnetic resonance imaging techniques.

Example of Dr. Armitage's research

High Field Nuclear Magnetic Resonance Facility at the University of Minnesota

Recent Publications

Burrill JS, Long EK, Reilly B, Deng Y, Armitage IM, Scherer PE, Bernlohr DA. Inflammation and ERStress Regulate Branched Chain Amino Acid Uptake and Metabolism in Adipocytes. Mol Endocrinology. (2015) 29 (3):411-420. DOI: 10.1210/me.2014-1275 PMCID: 4347289 PubMed

Symons, F. J., ElGhazi, I., Reilly, B. G., Barney, C. C., Hanson, L., Panoskaltsis-Mortari, A., Armitage, I. M. and Wilcox, G. L. (2015), "Can Biomarkers Differentiate Pain and No Pain Subgroups of Nonverbal Children with Cerebral Palsy? A Preliminary Investigation Based on Noninvasive Saliva Sampling. Pain Medicine." doi: 10.1111/pme.12545 PMCID:4332832 PubMed

Armitage, I.M., Drakenberg, T., Reilly, B. Use of 113Cd NMR to Probe the Native Metal Binding Sites in Metalloproteins: An Overview, Metal Ions Life Sciences (2013) p117-144, DOI 10.1007/978. PDF

El Ghazi, I., Martin, B. L., and Armitage, I. M., “New Proteins Found Interacting With Brain Metallothionein-3 are Linked to Secretion”, in a Special Issue on “Metals and Alzheimer’s Disease”, in International Journal of Alzheimer’s Disease, Volume 2011 (2011), Article ID 208634, 9 pages, 94-102. PMCID:3014675 PubMed

El Ghazi, I., Weng, S., Hu, S., Reilly, B., Lokensgard, J. R., Rock, B., Peterson, P. K., Wilcox, G. L., and Armitage, I. M., “Changes in the NMR Metabolic Profile of Human Microglial Cells Exposed to Lipopolysaccharide or Morphine”, J. of Neuroimmune Pharmacology, 5: 574-581 (2010). PubMed

El Ghazi, I., Martin, B. L., and Armitage, I. M., Metallothionein-3 is a Component of a Multiprotein Complex in the Mouse Brain", Exp Biol Med, 231, 1500-1506 (2006). PubMed

Martin, B.L. , Tokheim, A.M., McCarthy, P.T., Doms, B.S., Davis, A.A. and Armitage, I.M. "Metallothionein-3 and neuronal nitric oxide synthase levels in brains from the Tg2576 mouse model of Alzheimer's disease." Molecular and Cellular Biochemistry, 286, 129-136. (2006) PubMed

Lahti, D. W., Hoekman, J. D., Tokheim, A. M., Martin, B. L., and Armitage, I. M., "Identification of Mouse Brain Proteins Associated with Isoform 3 of Metallothionein", Protein Science, 14, 1151-1157 (2005). PubMed

Tokheim, A. M., Armitage, I. M., and Martin, B. L., "Antiserum Specific for the Intact Isoform-3 of Metallothionein", J. Biochem. Biophys. Methods, 63, 43-52 (2005). PubMed

Zangger, K. and Armitage, I. M., "Metallothionein" in Handbook of Metalloproteins , Volume 3, W. Bode, M. Cygler and A. Messerschmidt (eds) John Wiley & Sons, 351-364, (2004).

Cobine, P. A., McKay, R. T., Zangger, K., Dameron, C. T., and Armitage, I. M., "Solution Structure of Cu6 Metallothionein from the fungus Neurospora crass a," Eur. J. Biochem. (now FEBS J. ) 271 , 4213-4221 (2004). PubMed

Zangger, K. and Armitage, I. M. (2002) "Dynamics of Interdomain Interactions in Mammalian Metallothioneins," J. Inorg. Biochem., 88 ,(2), 135-143. PubMed

Zangger, K., Shen, G., Oz, G., Otvos, J.D. and Armitage, I.M., (2001) "Oxidative Dimerization in Metallothionein is a Result of Intermolecular Disulfide Bonds between Cysteines in the a-Domain," Biochem. J., 359, 353-360. PubMed

Oz, G., Zangger, K., and Armitage, I.M., (2001) "Three-dimensional Structure and Dynamics of a Brain Specific Growth Inhibitory Factor: Metallothionein-3," Biochemistry, 40, 11433-11441. PubMed

Zangger, K., Oz, G., Haslinger, E., Kunert, O. and Armitage, I.M., (2001) "Nitric Oxide Selectively Releases Metals from the N-terminal Domain of Metallothioneins: Potential Role at Inflammatory Sites," FASEB J., 15 (7): 1303-5. FASEB J

Zangger, K. Oz, G., and Armitage, I.M., (2000) "Re-evaluation of the Binding of ATP to Metallothioneins", J. Biol. Chem. 275:7534-8. PubMed.

Zangger, K. and Armitage, I.M. (2000) "The Accordian-HMQC:Heteronuclear Correlations Over a range of Coupling Constants," Magn. Reson. Chem. 38: 452-458.

Zangger, K., Oz, G., Otvos, J.D., Armitage, I.M. (1999) Three-dimensional solution structure of mouse [Cd7]-metallothionein-1 by homonuclear and heteronuclear NMR spectroscopy. Protein Sci. 8(12):2630-8. PubMed


5-130 NHH
312 Church Street
Minneapolis, MN 55455